FDA Investigator Henry K Lau
Henry K Lau has inspections in 1 countries as of 30 Aug 2023. Henry K Lau has collaborated with a combinined 2947 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
30 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Abdur Razzaque,
Alicia K Mckinsey,
Amir Alavi,
Andrea A Branche,
Andrea George, PhD,
Andrew B Slarve,
Andrew E Kay,
Andrew W Harmon,
Angel K Sandhu,
Angela D Wise,
Anh M Lac,
Anita Narula, PhD,
Anna J Vickrey,
Annie H Lam,
Ashar P Parikh,
Barbara J Arrais,
Barbara J Wilcox, PhD,
Bo Chi, PhD,
Brentley S Collins,
Calvin B Koerner,
Camacho,
Candace Y Gomez Broughton,
Carl Lee,
Carol A Elems,
Carole L Jones,
Carolyn A Renshaw,
CDR Ileana Barreto Pettit,
CDR Rochelle B Young, RPh, MSA,
Christian D Lynch (CDL),
Christine M Parmentier,
Christopher R Czajka,
Cynthia Jim, CSO,
Cynthia L Ford,
Daniel J Roberts,
David G Eng,
Doan T Nguyen, PharmD,
Dr. Guang Gao, PhD,
Dr. Mark J Seaton, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dustin P Tran,
Dustin R Abaonza,
Eileen A Liu,
Elsa Y Yu,
Emily Shacter,
Emmanuel Adu Gyamfi,
Eric L Dong, BS,
Erica R Pomeroy,
Farhana Khan,
Gene D Arcy,
Gerald Feldman,
Gerald M Feldman, PhD,
Gillenwater,
Gina M Hall,
Henry X Lau,
Hung H Do, MS,
Huy T Pham,
Jacqueline Mdiaz Albertini,
James C Yee,
James R Evans,
Jane M Kreis,
Janice Wai,
Jannifer L Degroot,
Jeanmaire Hryshko,
Jeanne A Young,
Jeanne Fringer, PhD,
Jeffrey M Watson,
Jeffrey P Raimondi,
Jennifer L Johnson,
Jenny K Yee,
Jessica B Darneille,
Joan T Briones,
John A Gonzalez,
Jolanna A Norton,
Joseph Kutze, PhD,
Joseph P Iser, MD,
Joseph Tibay,
Joshua S Hunt,
Joslyn K Brunelle, PhD,
Juliane Kjung Lau,
Karen D Phung,
Kathryn E King,
Keith O Webber, PhD,
Keith Webber, PhD,
Kevin P Foley,
Kouros Kangarli,
Kristin M Abaonza,
Kula N Jha,
Lakisha M Williams,
Lance M De Souza, MBA,
Laura Fontan, MS,
Laurie Graham,
Laurie P Norwood,
LCDR Jennifer H Rhyu,
Lealand Lee,
Leongc,
Linan Ha, PhD,
Linda S Shook,
Linh Tu,
Lisa Shin,
Lucila B Nwatu,
Lydia S Chan,
Mabel M Lee,
Maida Henesian (NMI),
Marie K Kinkade,
Marissa J Chan,
Mariza M Jafary,
Marsha W Major,
Marshalette Edwards,
Marshalette O Edwards,
Mei Chiung Huang (Jo),
Mei Chiung J Huang,
Michael Shanks, MS,
Michelle Rfrazier Jessen, PhD,
Mihaly S Ligmond,
Milos Dokmanovic, PhD,
Min Shanma Liu,
Natalia Pripuzova, PhD,
Nayan J Patel,
Nayan Patel,
Nicholas L Hunt,
Nicholas Obiri, PhD,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Paula A Trost,
Peter E Baker,
Peter Kessler, PhD,
Prabhu P Raju,
Qing Joanna Zhou, PhD,
Rachel C Harrington,
Randy L Elsberry,
Raymond T Oji,
Rebecca Rodriguez,
Rebecca T Davis,
Reyes Candau Chacon, PhD,
Riley C Myers, PhD,
Robert D Tollefsen,
Rose M Ashley,
Ruth Moore, PhD,
Sandra S Saniga,
Scott N Lim,
Serge Beaucage,
Sharon K Thoma, PharmD,
Shelley H Beausoleil,
Sherri J Jackson,
Sidney B Priesmeyer,
State Agency,
Stephanie A Slater, MS,
Steven C Himebaugh,
Stuart W Russell,
Thea C Grome,
Thomas J Arista,
Thomas R Withers,
Thuy T Nguyen, LCDR,
Timothy C Grome,
Truong Xuan Nguyen (Andy),
Uduak M Inokon,
Uttaniti Limchumroon (Tom),
Victoria Taylor,
William J Weis,
William V Millar,
Yi Wang, PhD,
Ying Xin Fan, PhD,
Yiyue Zhang (nmi), PhD
Henry K Lau's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| June, 2016 | FDA 483 | Jajco, Inc. DBA Anchor Drugs Pharmacy - Form 483, 2016-06-03 |
| February, 2008 | EIR | Grifols Diagnostic Solutions Inc. - EIR, 2008-02-01 |
| March, 2013 | FDA 483 | FVS Holdings, Inc. dba. Green Valley Drugs - Form 483, 2013-03-15 |
| September, 2013 | FDA 483 | Genentech, Inc. - Form 483, 2013-09-06 |
| March, 2014 | FDA 483 | Wedgewood Connect, LLC - Form 483, 2014-03-06 |
| May, 2013 | FDA 483 | Allure Labs, Inc - Form 483, 2013-05-24 |
| March, 2014 | FDA 483 Response | Wedgewood Connect, LLC - Form 483R, 2014-03-26 |
| September, 2011 | FDA 483 | Genentech, Inc. - Form 483, 2011-09-27 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more